103 related articles for article (PubMed ID: 947517)
1. The clinical usefulness of serum copper determinations in Hodgkin's disease. A retrospective study of 241 patients from 1963-1973.
Thorling EB; Thorling K
Cancer; 1976 Jul; 38(1):225-31. PubMed ID: 947517
[TBL] [Abstract][Full Text] [Related]
2. Serum copper, serum ceruloplasmin, and erythrocyte sedimentation rate measurements in children with Hodgkin's disease, non-Hodgkin's lymphoma, and nonmalignant lymphadenopathy.
Margerison AC; Mann JR
Cancer; 1985 Apr; 55(7):1501-6. PubMed ID: 3978543
[TBL] [Abstract][Full Text] [Related]
3. Serum copper compared to erythrocyte sedimentation rate as indicator of disease activity in Hodgkin's disease.
Asbjörnsen G
Scand J Haematol; 1979 Mar; 22(3):193-6. PubMed ID: 451449
[TBL] [Abstract][Full Text] [Related]
4. Serum copper in Hodgkin's disease in children.
Tessmer CF; Hrgovcic M; Wilbur J
Cancer; 1973 Feb; 31(2):303-15. PubMed ID: 4687877
[No Abstract] [Full Text] [Related]
5. Classification and prognostic value of serum copper/zinc ratio in Hodgkin's disease.
Cunzhi H; Jiexian J; Xianwen Z; Jingang G; Suling H
Biol Trace Elem Res; 2001 Nov; 83(2):133-8. PubMed ID: 11762530
[TBL] [Abstract][Full Text] [Related]
6. Prolonged observations on variations in the serum copper in Hodgkin's disease.
Warren RL; Jelliffe AM; Watson JV; Hobbs CB
Clin Radiol; 1969 Jul; 20(3):247-56. PubMed ID: 5808043
[No Abstract] [Full Text] [Related]
7. Serum levels of ceruloplasmin, properdin factor B and copper in lymphoma patients.
Casamassima A; Addabbo L; Caporusso L; Lorusso V
Int J Biol Markers; 1991; 6(3):183-7. PubMed ID: 1791312
[TBL] [Abstract][Full Text] [Related]
8. Value of serum copper levels and erythrocyte sedimentation rates as indicators of disease activity in children with Hodgkin's disease.
Wilimas J; Thompson E; Smith KL
Cancer; 1978 Oct; 42(4):1929-35. PubMed ID: 709539
[TBL] [Abstract][Full Text] [Related]
9. Serum ceruloplasmin levels in Hodgkin's disease and malignant lymphomas in correlation with serum copper levels.
Sirsat AV; Raste AS; Talavdekar RV; Advani SH
Indian J Cancer; 1979 Jun; 16(2):32-4. PubMed ID: 546729
[No Abstract] [Full Text] [Related]
10. Ceruloplasmin in Hodgkin's disease.
Koprivová H; Dienstbier Z; Sámal M; Foltýnová V
Neoplasma; 1982; 29(3):333-40. PubMed ID: 7133228
[TBL] [Abstract][Full Text] [Related]
11. Significance of serum copper levels in adult patients with Hodgkin's disease.
Hrgovcic M; Tessmer CF; Thomas FB; Fuller LM; Gamble JF; Shullenberger CC
Cancer; 1973 Jun; 31(6):1337-45. PubMed ID: 4709950
[No Abstract] [Full Text] [Related]
12. Significance of copper level in serum and routine laboratory parameters in estimation of outspreading of Hodgkin's lymphoma.
Jamakovic M; Baljic R
Med Arch; 2013; 67(3):185-7. PubMed ID: 23848039
[TBL] [Abstract][Full Text] [Related]
13. Interpreting serum copper levels in Hodgkin's disease.
Hrgovcic MJ; Tessmer CF; Mumford DM; Ong PS; Gamble JF; Shullenberger CC
Tex Med; 1975 Feb; 71(2):53-63. PubMed ID: 1111152
[No Abstract] [Full Text] [Related]
14. Elevated serum Cu in Hodgkin's disease and inhibitory effects of ceruloplasmin on lymphocyte response in vitro.
Larsen B; Heron I; Thorling EB
Eur J Cancer (1965); 1980 Mar; 16(3):415-21. PubMed ID: 6445273
[No Abstract] [Full Text] [Related]
15. Serum trace elements and Cu/Zn ratio in malignant lymphomas in children.
Gupta SK; Shukla VK; Gupta V; Gupta S
J Trop Pediatr; 1994 Jun; 40(3):185-7. PubMed ID: 8078119
[TBL] [Abstract][Full Text] [Related]
16. [Serum ferritin and other biological parameters as indicators of tumor activity in Hodgkin's disease].
Hermosa V; Mazo E; Baró J; Castillo E; Cordovilla JJ; Carril J; Zubizarreta A
Sangre (Barc); 1985; 30(2):154-8. PubMed ID: 2409612
[No Abstract] [Full Text] [Related]
17. Plasma iron and copper in Hodgkin's disease. A comparison with other laboratory indicators.
Gobbi PG; Scarpellini M; Minoia C; Pozzoli L; Perugini S
Haematologica; 1979 Aug; 64(4):416-32. PubMed ID: 121577
[No Abstract] [Full Text] [Related]
18. The strong correlation between serum copper level and the copper/zinc ratio to histopathological changes, clinical stage, and prognosis of Hodgkin's disease.
Gözdaşoğlu S; Akar N
Biol Trace Elem Res; 2003 Feb; 91(2):191-2. PubMed ID: 12719614
[No Abstract] [Full Text] [Related]
19. Value of laboratory indicators in Hodgkin's disease: preliminary results.
Ray GR; Wolf PH; Kaplan HS
Natl Cancer Inst Monogr; 1973 May; 36():315-23. PubMed ID: 4744591
[No Abstract] [Full Text] [Related]
20. Serum copper assay as a biochemical marker to assess the response to therapy in Hodgkin's disease.
Kesava Rao KV; Shetty PA; Bapat CV; Jussawalla DJ
Indian J Cancer; 1977 Dec; 14(4):320-4. PubMed ID: 612553
[No Abstract] [Full Text] [Related]
[Next] [New Search]
